CKD stage 1 (eGFR ≥ 90 ml/min/1.73 m2) | CKD stage 2 (eGFR 60–89 ml/min/1.73 m2) | CKD stage 3 (eGFR 30–59 ml/min/1.73 m2) | CKD stage 4 and 5 (eGFR b30 ml/min/1.73 m2) | P value* | |
---|---|---|---|---|---|
Diseases | |||||
Diabetes mellitus, n (%) | 11 (1.2) | 401(45.5) | 457(51.8) | 13(1.5) | ˂ 0.001 |
Hypertension, n (%) | 25(1.8) | 658(47.8) | 676(49.1) | 19(1.4) | ˂ 0.001 |
Dyslipidemia, n (%) | 43(3.7) | 611(52.6) | 494(42.5) | 13(1.1) | 0.09 |
IHD, n (%) | 18(2.7) | 331(49.0) | 319(47.2) | 8(1.2) | ˂ 0.001 |
Myocardial infarction, n (%) | 5(3.4) | 71(48.6) | 69(47.3) | 1(0.7) | ˂ 0.001 |
Stroke, n (%) | 1(0.9) | 57(50.9) | 53(47.3) | 1(0.9) | 0.26 |
Kidney failure(self-reported), n(%) | 0(0) | 12(22.6) | 29(54.7) | 12(22.6) | ˂ 0.001 |
Individual habits (illicit drug, Cigarette and alcohol) | |||||
Smoking, n (%) | 62(8.2) | 465(59.5) | 247(31.6) | 6(0.8) | ˂ 0.001 |
Opium Consumption, n (%) | 38(10.8) | 218(62.1) | 95(27.1) | 0(0) | ˂ 0.001 |
Alcohol Consumption, n (%) | 5(6.9) | 41(56.9) | 26(36.1) | 0(0) | 0.39 |
BMI | |||||
Underweight (˂19),n (%) | 20(16.8) | 77(64.7) | 20(16.8) | 2(1.7) | ˂ 0.001 |
50(5.1) | 626(63.7) | 303(30.8) | 4(0.4) | ||
34(3.0) | 598(52.1) | 506(44.1) | 9(0.8) | ||
Obesity (˃30), n (%) | 11(4.2) | 308(42.5) | 399(55/1) | 6(0.8) | |
MET | |||||
Low (˂ 3), n (%) | 7(4.8) | 72(49.0) | 64(43.5) | 4(2.7) | ˂ 0.001 |
90(3.3) | 1464(53.7) | 1156(42.4) | 17(0.7) | ||
Heavy (˃6), n (%) | 18(15.8) | 84(73.7) | 12(10.5) | 0(0) |